The genus Leishmania comprises a group of parasitic protozoan species which infect over 10 million people worldwide (70) . The parasite undergoes several developmental transitions, alternating between an extracellular transmissible form, which is carried in the gut of phlebotomine sand flies, and an intracellular form, which resides within the phagolysosome of vertebrate macrophages. The genome of the parasite has been shown to be quite plastic, undergoing a number of mutational and recombinational events including deletions, gene amplifications, chromosomal rearrangements, and alterations in ploidy (2, 4, 7, 20, 47, 54, 59, 66) . Many of these have been implicated in biological phenomena such as drug resistance and virulence, making their study relevant to the understanding and control of this important disease.
To undertake laboratory studies of genomic change, one usually begins with the identification of mutants exhibiting the desired phenotype. This has been readily accomplished for dominant mutations, especially those mediating drug resistance by gene amplification (7, 54) . However, our understanding of genomic changes conferring recessive phenotypes has been limited by the fact that this primitive eukaryote is effectively an asexual diploid (4, 18, 38, 64) . While the discovery of occasional hybrid leishmanias in field isolates suggests at least the possibility of genetic exchange (reviewed in reference 51), neither we nor others have been able to demonstrate genetic exchange in experimental crosses in vitro or in the sand fly vector (reference 55 and references therein).
Diploidy without sex poses considerable challenges to those seeking to obtain mutants, a problem noted in previous studies of other asexual diploids including cultured mammalian cells and some Candida species (61, 69) . Since two events are required, recessive mutants rarely occur, and thus selective rather than screening methods must be used to identify them. For diploid Leishmania cells, the frequency of recovery of recessive mutants is estimated to be less than 10 Ϫ7 after mutagenesis (38, 40) . When strong selective methods are available, this barrier can be overcome, as shown for drug resistance (7, 9, 17, 38, 40, 54) and lectin selections against an important surface glycolipid of Leishmania species, lipophosphoglycan (24, 41) . For lipophosphoglycan mutants, it has proven possible to apply functional rescue approaches to identify the defective gene (23, 60) . However, in studies of pathogens, a most desired mutant class affects virulence and survival within the host, and selections for avirulence are often not readily devised. Improved methods for generating Leishmania mutants would prove invaluable in genetic studies of pathogenesis in this organism, and basic studies of the frequency, type, and induction of mutations in the Leishmania genome would be helpful in this regard.
Targeted mutagenesis of asexual diploids also requires the inactivation of two alleles. This was accomplished in Leishmania spp. and other species by conducting two rounds of targeting with independent selectable markers (19, 44, 63) . This places a burden on the number of selectable markers required if one wishes to inactivate several loci and is experimentally tedious, because one must apply two different targeting vectors for each locus. Moreover, once inserted, the markers themselves may compromise further manipulations or have undesirable consequences (32) . For this reason, a number of schemes have been developed to permit conservation or recycling of selectable markers (1, 12, 31, 36, 52) .
Here we have developed a system that permits the measurement of several types of genomic change occurring at the DHFR-TS locus in Leishmania major. In L. major, as in all protozoan and plant species known, the genes encoding dihydrofolate reductase (DHFR) and thymidylate synthase (TS) have been joined to generate a bifunctional fusion protein (8, 45) . First, we show that it is possible to select against the activity of the DHFR-TS protein by plating parasites in the presence of methotrexate plus thymidine (MTXϩTdR). Since DHFR-TS activity can be selected for in the absence of exogenous TdR (18) , DHFR-TS thus may be used as a positivenegative marker in L. major. We used the negative DHFR-TS selection in several ways: to characterize several types of genomic change in L. major, including loss of heterozygosity (LOH) and the induction of defective DHFR-TS proteins; to probe and quantitate the effect of mutagenic treatments on L. major; and to measure the emergence of LOH in heterozygous replacement parasites (ϩ/HYG) subjected to elevated hygromycin B pressure, a method which conserves markers and is applicable at loci not amenable to negative selections (52) . Finally, we used negative DHFR-TS selection in a protocol we term null targeting, which simultaneously deletes both copies of the chromosomal DHFR-TS gene without inserting any selectable marker. This approach, which could potentially be applied to other diploid organisms, was used here to generate a marker-free dhfr-ts Ϫ mutant parasite that has some potential as an attenuated vaccine for leishmaniasis (65) . In total, our findings have important implications for our understanding of targeted and random mutations within the Leishmania genome and other asexual diploids.
MATERIALS AND METHODS
Cell lines, culture, and transfection. All cell lines studied were derivatives of the L. major clonal line CC-1 (39) . CC-1 is diploid and homozygous at DHFR-TS (ϩ/ϩ); clone E8-5C7 has a heterozygous replacement of the DHFR-TS gene with a hygromycin B resistance marker (ϩ/HYG), and E10-5A3 is a clonal dhfr-ts Ϫ knockout that is heterozygous for replacements of DHFR-TS with a G418 resistance marker (NEO) and HYG (NEO/HYG) (19) . Promastigotes were cultivated in M199 medium containing 10% heat-inactivated fetal bovine serum (39) or, for tests of thymidine prototrophy, in a completely defined M199 medium lacking thymidine and supplemented with 0.66% bovine serum albumin (Cohn fraction V), 4 g of folate per ml, 1.5 g of biopterin per ml, 100 M adenine, 10 g of heme per ml, 40 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES; pH 7.4), 50 U of penicillin per ml, 50 g of streptomycin per ml, and 1 g of biotin per ml. As indicated, liquid medium contained G418 (8 g/ml), hygromycin B (16 g/ml), or thymidine (10 g/ml). Cells were enumerated with a Coulter Counter (model Zf). The concentration of MTX required to inhibit cell growth by 50% was termed the EC 50 . Log-phase promastigotes were transfected by electroporation, and colonies were obtained by plating cells on semisolid M199 medium (39) . In MTX selections, colonies appeared after 8 to 20 days. As indicated, the plates were supplemented with G418 (16 g/ml), hygromycin B (32 g/ml), thymidine (TdR; 10 g/ml), or methotrexate (MTX; 100 M). The plating efficiency was determined in parallel on medium containing only hygromycin B and TdR.
Mutagenesis. For mutagenic treatments, log-phase cells (4 ϫ 10 6 to 8 ϫ 10 6 /ml) were suspended at 5 ϫ 10 6 /ml in M199 medium. MNNG (N-methyl-NЈ-nitro-N-nitrosoguanidine [Sigma Chemical Co]) was added to a final concentration of 0.6 g/ml, and the cells were incubated for 4 h at 25ЊC. ␥ irradiation was carried out with a 60 Co source for times designed to yield doses of 500 or 5,000 rads. Immediately after mutagenesis, viability was determined by plating aliquots of control and mutagenized cells on nonselective medium. The remaining cells were diluted to 10 6 /ml in fresh medium and allowed to grow for 2 days before being plated on MTX-TdR. The fraction of LOH cells was determined by cell slot blots (described below).
DNA manipulations. Leishmania genomic DNA was prepared by the TritonLiCl miniprep method (49) and used for Southern blot analysis as described previously (27) . Cell slot blots were made as follows. Aliquots (0.1 ml) of stationary-phase cultures were applied to nylon membranes (GeneScreen Plus), prewetted with 2ϫ SSPE (1ϫ SSPE is 0.15 M NaCl, 10 mM NaH 2 PO 4 , and 1 mM EDTA), with a slot blotter apparatus (Schleicher & Schuell). The cells were lysed by treatment in 0.4 N NaOH-1.5 M NaCl for 10 min and then neutralized in 0.5 M Tris HCl (pH 7.5)-3 M NaCl for 10 min. The DNAs were immobilized by baking, and hybridization was carried out as for the Southern blots. Final washes were performed at 67ЊC in 0.1ϫ SSPE-0.5% sodium dodecyl sulfate. The DHFR-TS coding-region probe fragment was generated by PCR with genomic DNA as a template and the following primers: sense, 5Ј-cctctagaggtaccATATG TCCAGGGCAGCTGCGA; antisense, 5Ј-CCCACGCCGGTGCGGTCCTCCT T-3Ј (lowercase letters represent nucleotides added to generate restriction sites and are not present in Leishmania DNA). The HYG gene probe was a 1.05-kb BamHI-SpeI fragment from pX63HYG (19) . The DHFR-TS locus "near flanking" probe was a 2.0-kb EcoRI fragment from pK300 (39) , and the "far flanking" probe was a 5.7-kb KpnI fragment from plasmid pLTS-D4AJ11-K57 (6). The Leishmania actin probe was a 1.7-kb SacI fragment derived from genomic DNA subcloned in pBluescript (21) . All DNA probes were labeled with [␣-32 P]dCTP by the random-primer method (29) .
Enzyme and transport assays. Crude extracts were prepared by sonication of cells in phosphate-buffered saline (137 mM NaCl, 15 mM KCl, 10 mM Na 2 HPO 4 , 32.6 mM KH 2 PO 4 ) containing 1 mM EDTA, 100 M phenylmethylsulfonyl fluoride, 150 g of benzamidine per ml, 20 g of leupeptin per ml, 200 g of 1,10-phenanthroline per ml, and 50 g of soybean trypsin inhibitor per ml. Extracts were centrifuged at 13,000 ϫ g for 20 to 30 min at 4ЊC, and the supernatants were taken for enzyme assay. DHFR (26) . Total soluble protein was determined by the dye-binding method (10) . Pteridine reductase 1 (PTR1) protein levels were determined by Western blot (immunoblot) analysis (35) with a rabbit polyclonal antiserum (53) .
RESULTS
Selection against DHFR-TS in L. major. In prokaryotes, loss of TS activity confers transient resistance to antifolates if thymidine is provided (5, 62) . This stems from a sparing of reduced-folate pools, since TS is the only significant enzyme whose activity oxidizes tetrahydrofolates. We predicted that the absence of the bifunctional DHFR-TS would confer a similar if not stronger phenotype in Leishmania spp. as a result of linkage of the two enzymatic activities. We tested this with a panel of cells, obtained by homologous gene replacement, which contained either one (ϩ/HYG) or no (NEO/HYG) copies of DHFR-TS. In liquid media, wild-type or heterozygous cells show typical sensitivities to MTX (EC 50 s, about 1 M), while the dhfr-ts Ϫ NEO/HYG knockout grew well at 100 M MTX (Fig. 1) . Permanent MTX resistance may arise from the provision of reduced folates by the alternate pteridine reductase PTR1 in L. major (4a) .
These data suggested that MTX-TdR could be used as a selection against Leishmania DHFR-TS. Accordingly, 2 ϫ 10 6 20 ϫ 10 6 ϩ/HYG Leishmania cells were plated on medium containing MTX-TdR, and colonies appeared at a frequency of 0.7 ϫ 10 Ϫ5 to 2.5 ϫ 10 Ϫ5 per cell plated (Table 1 ). In contrast, wild-type cells bearing two copies of DHFR-TS (ϩ/ϩ) did not give rise to any colonies. Omission of TdR also gave no colonies, suggesting that those obtained with TdR did not arise from common MTX resistance mechanisms, such as amplification of DHFR-TS or PTR1, mutations in DHFR, or from altered MTX accumulation, as described previously for numerous Leishmania lines and species (2, 7, 9, 25) .
Cell blot hybridizations were performed to determine whether the colonies obtained by MTX-TdR selection of the ϩ/HYG line contained DHFR-TS sequences. Remarkably, 75% (18 of 24) of the colonies lacked DHFR-TS, while the remaining 25% (6 of 24) were positive and thus retained the gene in some form (Table 1 ; Fig. 2 ). In the following discussion, we will refer to these two colony types as DTS⌬ and DTSϩ, respectively. As expected, all DTS⌬ lines were functionally thy Ϫ , and we show below that many of the DTSϩ lines have reduced TS activity (Table 2) . Thus, as in prokaryotes, this selection yields mutations affecting TS.
DTS⌬ lines have undergone a LOH event. We used Southern blot hybridization to probe the structure of the DHFR-TS locus in the DTS⌬ lines. A DHFR-TS coding-region probe ( 3B) . A wild-type structure was also found in Southern blots with a probe (pK300 [39] ) encompassing 30 kb of DNA spanning DHFR-TS (data not shown). Moreover, no changes in the size of the 500-kb DHFR-TS chromosome could be detected in contour-clamped homogeneous electric field gel electrophoresis blots hybridized with a probe located 100 kb 5Ј of DHFR-TS (Fig. 3C , probe F, and data not shown). Thus, the DTSϩ and DTS⌬ lines have not undergone deletion or DNA rearrangements.
We measured the HYG copy number in several DTSϩ and DTS⌬ lines in Southern blot ( Fig. 3 ) and slot blot analysis, using hybridization with a Leishmania actin probe to control for DNA loading. Assuming the HYG copy number in the Table 2 ). In combination with the Southern blot data described above, it appeared that the LOH event in the DTS⌬ lines did not occur by chromosome loss but arose from an event where loss of the DHFR-TS allele was coupled to duplication of the HYG allele. Potential mechanisms include gene conversion, mitotic crossing over, or some form of chromosome mis-segregation. Characterization of DTS؉ colonies. We examined several of the DTSϩ colonies arising from MTX-TdR selection of the ϩ/HYG line for their sensitivity to MTX (with or without TdR) and for factors associated with MTX resistance in Leishmania spp. These included DHFR or TS activity, PTR1 protein levels, and MTX uptake ( Table 2 ). Some DTSϩ lines obtained after mutagenesis of ϩ/HYG and selection in MTX-TdR (see below) were also included. No alterations in MTX uptake (Table  2 ) or PTR1 levels (data not shown) were found.
The DTSϩ lines exhibited a diverse array of phenotypes. All lines exhibiting high levels of MTX resistance (Ͼ50 M) showed dramatic reductions in TS activity, not different from background levels ( Table 2) . One of these lines showed normal DHFR activity (MNNG1), while the remaining four lines showed reduced DHFR activity ranging from 0 to 25% of the wild-type activity ( Table 2) . As biochemical studies and the 3 . Structure of the DHFR-TS locus in DTS⌬ and DTSϩ clones. Total DNA of several DTS⌬, DTSϩ, and control lines was prepared, digested with the indicated restriction enzymes, electrophoresed through 0.8% agarose gels, and transferred to nylon membranes for Southern blot analysis. Control cell lines were wild type (ϩ/ϩ); ϩ/HYG, heterozygous DHFR-TS replacement clone E8-5C7; and CBrev, DHFR-TS "hemizygote" (line CBrev3, containing a 30-kb deletion of one DHFR-TS allele [19] ). Lines LH1, LOH 5-1, LOH 5-2 and LOH 5-3 represent the DTS⌬ class and arose from experiments 1 and 5 ( Table 1) . Lines F4, F22, PM13, and PM23 represent the DTSϩ class (see Table 2 (33) and TS-independent pathways for de novo synthesis of thymidylate have not been described (43) . One possible explanation arises from the fact that in other organisms, only 1% of normal TS activity is sufficient for survival (16) . We suspect that in vivo, low levels of TS undetectable by in vitro assays could provide sufficient activity for growth. Another group of DTSϩ lines (colonies PM13 and F22) exhibited moderate MTX resistance (around 10-fold in the presence of TdR), but were otherwise wild type ( Table 2 ). The MTX sensitivity of DHFR activity in lines PM13 and F22 was comparable to that in the wild type (IC 50 s of 1.5 to 3.0 nM for PM13 and F22 versus 1.5 to 2.0 nM for the wild type), and no evidence of gene amplification of DHFR-TS, PTR1 or any other region of DNA was found in restriction digests of total genomic DNA (reference 17 and data not shown). These lines may represent an unanticipated class of MTX resistance mutations not involving the activities measured here. Finally, some lines, like S7 and S8, were indistinguishable from the ϩ/HYG parent in terms of MTX sensitivity, DHFR and TS activities, and MTX uptake ( Table 2) . These lines were originally scored as having a small-colony phenotype on MTX-TdR plates and probably were "breakthroughs" escaping the selection. These studies thus confirm that most of the DTSϩ Leishmania strains arising from selection with MTX-TdR bear the expected mutations affecting TS activity.
Spontaneous frequency of LOH in Leishmania populations and clones. To determine the spontaneous frequency of LOH at the DHFR-TS locus of L. major, we carried out four experiments, using the original ϩ/HYG line as well as several clonal derivatives obtained immediately after plating on hygromycincontaining solid medium. The frequency of colonies on MTXTdR plates ranged from 0.7 ϫ 10 Ϫ6 to 4.4 ϫ 10 Ϫ5 , or from 0.6 ϫ 10 Ϫ6 to 3.8 ϫ 10 Ϫ4 after correcting for plating efficiency (Table 1) . Within an experiment, the uncorrected frequency for different ϩ/HYG clones varied by less than 2-fold, yet among experiments, the uncorrected frequency differed by more than 40-fold (experiments 4 and 5). In experiment 5, the original ϩ/HYG line gave a 20-fold higher frequency than its recloned descendants, although this trend is not evident in other similar comparisons in Table 1 . We cannot account for the wide range observed, and no trend was evident over the course of our experiments. An intriguing speculation is that the variability may reflect the presence of trace levels of parasites aneuploid for the DHFR-TS chromosome. The occurrence of aneuploid parasites and their potential effects on homozygosity in Leishmania species have been discussed previously (20) .
Examination of representative colonies from each experiment showed that as in the first, most of the colonies lacked DHFR-TS and thus belonged to the DTS⌬ class (Table 1) . In experiments 4 and 5, all of the colonies were DTS⌬. Assuming that 30 cell doublings were required to obtain sufficient cell numbers following plating of single cells for our studies of fresh clones, that the majority of colonies obtained have lost DHFR-TS, and that these events occurred de novo, we calculated a rate of LOH (events per cell generation) ranging from 0.2 ϫ 10 Ϫ7 (Table 1 , experiment 5) to 1.3 ϫ 10 Ϫ5 (experiment 4). This range overlaps that of 10 Ϫ5 to 10 Ϫ6 observed in mammalian cells (52) .
Effects of mutagenic treatments. Although mutagenic treatments have been used successfully to generate a number of interesting Leishmania mutants (24, 38, 40, 41, 48) , their effects and potency have not been well characterized. We reasoned that the frequency and nature of the events induced by mutagenic treatment of Leishmania cells could be analyzed following MTX-TdR selection of the ϩ/HYG heterozygote. We examined the alkylating agent MNNG and ␥ irradiation with a 60 Co source. The cells were treated with mutagen, allowed to recover for 2 days in M199 medium supplemented with TdR (about four cell doublings), and then plated on MTX-TdR media to score for the effects.
Treatment with 0.6 g of MNNG per ml resulted in only a small decrease in viability (44%) but led to a 70-fold increase in the frequency of colonies arising in selective plates (Table  3) . This reflected primarily an increase in the frequency of DTSϩ colonies of about 1,500-fold (this value is approximate because of the very small number of DTSϩ colonies observed in the control and the potential occurrence of events not affecting DHFR-TS). The frequency of DTS⌬ colonies increased fivefold as well. Similarly, exposure to 500 and 5,000 rads of ␥ irradiation resulted in a 20-and 24-fold increase, respectively, in the frequency of colonies on selective plates, although the higher dose caused a considerable loss in viability (Ͼ90%) ( Table 3) . Unlike the effects noted with MNNG, the increase from ␥ irradiation arose primarily from an increase in the DTS⌬ class (Table 3) .
These studies showed (i) that the spontaneous frequency of the DTSϩ class is about 10 Ϫ7 to 10 Ϫ6 , which is in the range expected from studies in other organisms, and (ii) that MNNG acts primarily to increase the number of point mutations (DTSϩ colonies) whereas ␥ irradiation acts primarily to increase the frequency of LOH at the DHFR-TS locus. DHFR-TS as a negative marker in primary transfections. We reasoned that it might be possible to use selection against DHFR-TS in primary transfection experiments. To test this, we used a 7.8-kb BglII targeting fragment derived from plasmid pR, which contains a deletion of the whole DHFR-TS coding region (Fig. 4C) (39) . Homologous replacement at DHFR-TS by this fragment would be expected to yield a deletion of the gene (Fig. 4C) . To exhibit the desired dhfr-ts Ϫ phenotype following transfection of diploid wild-type cells, two events were required, either two independent replacements or one replacement combined with LOH.
Ten micrograms of the purified targeting fragment or an equimolar amount of BglII-digested pR was electroporated into wild-type L. major, and the cells were plated on MTXTdR. Seven colonies were obtained in the transfected cells, four of which were thy Ϫ . In contrast, two colonies were obtained in mock-transfected controls, both of which were thy ϩ . All five thy ϩ colonies were noticeably smaller than the thy Ϫ colonies, and we presume that they represent the expected background of events involving known MTX resistance mechanisms, structural alterations of TS, or breakthroughs (Table  2) . In contrast, cell and Southern blot analysis of the four thy Ϫ colonies showed that three contained the planned homozygous deletion (clones C1, C2, and C5 [ Fig. 4A] ). Hybridization with a DHFR-TS probe confirmed the loss of DHFR-TS (Fig. 4B) . The fourth (D1) contained one deletion allele plus another bearing a more complex event which also resulted in deletion of DHFR-TS (Fig. 4A and B and data not shown). Similar complex events have been described previously at DHFR-TS in cells transfected with large amounts of targeting fragment (18) . The presence of two distinct alleles in this clone suggests that they arose from separate replacement events. For the other three thy Ϫ colonies, we cannot presently discern whether two replacements or a single replacement followed by LOH occurred. Regardless of the mechanism, these data demonstrate the feasibility of direct selection against DHFR-TS in diploid wild-type L. major.
Positive selection for LOH. Mortensen et al. (52) showed that selection of a ϩ/NEO heterozygote mouse embryonic stem cell with elevated G418 pressure yielded NEO/NEO homozygotes. We tested whether a similar approach would be feasible in L. major, because selection against the wild-type gene would not be possible for most loci.
Normally, the ϩ/HYG parasite was propagated in medium lacking TdR and containing 16 g of hygromycin B per ml. Several independent cultures of this line were serially passaged in medium containing TdR and either 250 or 500 g of hygromycin B per ml (for the ϩ/HYG line, 200 g of hygromycin B per ml results in a 50% reduction in growth). At the higher drug concentrations, a decreased rate of growth was observed initially but the cultures rapidly adapted and grew at nearnormal rates thereafter. After 9 to 12 passages (each at a 1:100 dilution, for a total of 60 to 80 cell doublings), the frequency of colony formation on MTX-TdR plates rose dramatically, ranging from 0.001 to 0.95 in different cultures. Both concentrations of hygromycin B worked equally well. Similar results were obtained by selecting the NEO/HYG dhfr-ts Ϫ knockout in an analogous fashion, which yielded a HYG/HYG knockout homozygote (data not shown).
We measured the rate of increase of colony formation on MTX-TdR plates as a function of the period of growth at higher hygromycin B concentrations. On average, every three passages resulted in about a 10-fold increase in colony formation (Fig. 5) . Again, no correlation was found between hygromycin B concentration and the frequency of colonies on MTXTdR plates. We did not systematically examine the DHFR-TS phenotype in the colonies arising from these studies, but those tested always belonged to the DTS⌬ class (data not shown). Thus, elevated drug pressure can be used effectively to induce homozygosity from heterozygous replacements in L. major. systems. In this work, we have used studies of the DHFR-TS locus to develop a system for probing basic mechanisms of genomic change and to develop new approaches for genetic manipulation in this important pathogen. DHFR-TS as a positive/negative marker in Leishmania spp. Our data show that under proper conditions, selection against DHFR-TS can be performed in Leishmania spp. Using several protocols involving plating on selective media containing the antifolate MTX plus TdR, we obtained numerous parasite colonies, virtually all of which showed loss of the DHFR-TS structural gene or alterations in the TS enzyme (Tables 1 to 3) . Thus, the "classical" anti-TS selection works in Leishmania spp. as well as it has in bacteria, yeasts, and cultured mammalian cells (3, 5, 11, 62) . In Leishmania spp. and other taxa with a bifunctional DHFR-TS protein, such as protozoa and plants, the selection may actually be more stringent, because inhibition of DHFR would be absolute following genetic inactivation or deletion ( Table 2) .
DISCUSSION
The facile generation of null dhfr-ts Ϫ mutants by a single transfection step with a null deletion targeting construct permits the generation of auxotrophic thy Ϫ L. major. Direct selection for auxotrophs in Leishmania spp. was not reported previously because of the difficulty in simultaneously inactivating both alleles in this asexual diploid organism. In thy Ϫ auxotrophs, DHFR-TS may be used as a positive selectable marker (18, 33) . Thus, DHFR-TS can be manipulated as a positive/ negative marker in a way similar to the URA3 gene of Saccharomyces cerevisiae and potentially has many uses in genetic analysis of this parasite. One caveat is that selection against DHFR-TS is restricted to chromosomally borne genes, because DHFR-TS overexpression mediated by multicopy plasmids confers MTX resistance even in the absence of thymidine (14) . Another caveat is that it may not be possible to eliminate DHFR-TS in all strains (20) . In these situations, the herpes simplex virus thymidine kinase gene would be a more appropriate negative marker (46) .
The nature of LOH in Leishmania spp. The most common event observed following plating of a ϩ/HYG heterozygote L. major on anti-DHFR-TS selective media is LOH, resulting in a complete loss of the DHFR-TS gene (DTS⌬ class [ Table 1 ; Fig.  2] ). These colonies showed no alterations in the 30-kb region surrounding the DHFR-TS locus or in the size of the DHFR-TS chromosome, thereby ruling out models involving gene deletion. Quantitative Southern and cell slot blot analysis showed that DTS⌬ colonies contained two copies of the HYG allele, suggesting that simple chromosome loss is not responsible (it should be noted that our data do not exclude deletion or loss events, because these could represent minor classes).
There are several possible models for the origin of the DTS⌬ phenotype. These include gene conversion, mitotic crossover, or chromosome mis-segregation, and all three have been invoked in previous studies of LOH (15, 52, 57, 68) . To discriminate amongst these models, flanking markers capable of distinguishing the two DHFR-TS chromosomes would be required. In general, the degree of heterozygosity in cultured Leishmania cells is low (4, 51) , perhaps because of the phenomenon of LOH described here. In any event, we have not found a heterozygous marker in the CC-1 line of L. major used here (6) , and thus the flanking markers necessary to probe the mechanism of LOH are not presently available.
The occurrence of LOH in random and targeted mutagenesis in Leishmania spp. Our data show the spontaneous occurrence of LOH at the DHFR-TS locus with a frequency of up to 10 Ϫ4 (Tables 1 and 3 ), corresponding to a rate of up to 10 Ϫ5 cell per generation. This frequency and rate are similar to those reported for other organisms (52) . The magnitude of this effect relative to the frequency of spontaneous mutation (less than 10 Ϫ6 /allele) and DNA transfection (less than 10
Ϫ4
) suggests that LOH may play an important role in shaping the parasite genome both in nature and in the laboratory. Moreover, it is likely that the mechanisms leading to LOH contribute to the low frequency of heterozygotes observed in natural parasite populations (4, 51) , especially if the frequency of genetic exchange is low.
Current data suggest that the contribution of LOH to both targeted and random mutagenesis in Leishmania spp. may be quite significant. In numerous targeted-replacement experiments, alteration of only one allele is commonly found, thus mandating a second targeting round to obtain the desired knockout. Occasionally, alterations at both alleles have been noted; these can be heterozygous or homozygous (Fig. 4) (18, 56) . Both classes of events have been attributed to the generally high frequency of targeted replacement in Leishmania spp. (18, 56) , although only the heterozygous class unambiguously arises from independent events. Our studies now suggest the possibility that the single-step homozygous replacements arose by a single replacement followed by LOH. The fortuitous occurrence of LOH at heterozygous replacements was noted previously by Mortensen et al. (52) , and our data suggest that a similar process could occur in Leishmania spp. (Fig. 5) , especially if high selective drug concentrations are used.
It is commonly believed that the majority of recessive mutations in mammalian cells arise from mechanisms involving some form of LOH (15, 52, 57, 68) . Random mutagenesis with MNNG has been used to induce a number of mutations in diploid Leishmania cells (24, 38, 40, 41) , four of which have been characterized at the molecular level (22, 23) . Three of these are homozygous deletions, and only one is heterozygous. Thus, the emerging data set suggests that mutants often arise through mechanisms involving LOH in Leishmania spp. as well.
The prevalence of LOH-type events in the generation of mutants recovered from diploid organisms may simply reflect the relative frequencies of point mutagenesis and LOH. For example, from the data in Table 3 , we calculated that in diploid Leishmania cells, mutants arising from a point mutation and LOH should occur more than 20-fold more frequently than mutants requiring two independent point mutations. However, recent studies suggest that mutational and LOH mechanisms may not be independent, since the frequency of homozygous mutants in diploid S. cerevisiae is more than 1,000-fold higher than expected (28) . Interestingly, the frequency of recovery of homozygous mutants in one-step selections of transfected Leishmania cells (ca. 10 Ϫ7 [Fig. 4 ] [56] ) is greater than that calculated for independent replacements (less than 10 Ϫ8 ). This may signal a similar lack of independence in the events affecting both alleles.
Applications to mutagenesis and genetics of Leishmania spp. Our studies provide the first estimate of the frequency of point mutations at the DHFR-TS locus in L. major, somewhat less than 10 Ϫ6 (Table 3 ). This value is comparable to that observed in a wide range of other organisms for loss-of-function mutations (30) and may be compared to the mutation rate of 1 ϫ 10 Ϫ7 to 9 ϫ 10 Ϫ7 observed in Trypanosoma brucei for inactivation of an integrated thymidine kinase (TK) gene (67a). Interestingly, these studies did not yield trypanosomes exhibiting LOH. However, the trypanosomes tested also bore a cointegrated NEO resistance marker, and G418 selection was maintained during negative selection against thymidine kinase. LOH events affecting TK but not NEO would be much less common than those affecting TK alone, and the failure to recover them is not surprising.
The frequency of point mutants (DTSϩ class) was elevated greatly following mutagenic treatments, more than 1,500-fold by the alkylating agent MNNG and 10-fold following irradiation (Table 3 ). In contrast, the frequency of LOH rose 10-fold in response to MNNG and more than 20-fold after ␥ irradiation (Table 3 ). Although limited, these studies suggest that the mutational spectrum induced by these classic mutagens in L. major resembles that observed in other organisms (30) . Quantitative analysis of the frequency and types of mutations recovered in response to different mutagenic treatments, in combination with the appreciation of the role of LOH, may prove helpful in the design of protocols for increasing the yield of Leishmania mutants. This is important since the general unavailability of recessive mutants is currently a limitation in the application of functional complementation approaches in this organism.
The system established here has several direct applications. First, the defective DHFR-TS mutants (Table 2 ) may prove useful in studies exploring the role of particular amino acids in the activity or stability of this key metabolic protein. Second, it will be possible to characterize the type and frequency of mutations induced by other mutagenic treatments and to incorporate these data into improved mutant recovery protocols as outlined above. It would be particularly interesting to examine the effects of oxidative stress on mutagenesis, since the entry of Leishmania cells into and propagation within the phagolysosome of the vertebrate macrophage may expose the parasite to this class of DNA-damaging agents as part of the normal infectious cycle. Interestingly, studies of Salmonella spp. have stressed the importance of DNA repair in the expression of virulence (13) . Potentially, measurement of alterations at DHFR-TS within the DHFR-TS/HYG heterozygote could be used as a probe of the exposure of Leishmania spp. to mutagenic stress during the natural infectious cycle.
The occurrence of LOH has important uses in the conservation of genetic markers in transfectional manipulations of the Leishmania genome. Following the protocol of Mortensen et al. (52) , we showed that selection of a ϩ/HYG DHFR-TS heterozygote with elevated hygromycin B levels rapidly gave rise to thy Ϫ parasites completely lacking DHFR-TS (Fig. 5 ). This permits the use of a single targeting construct and transfection to obtain null mutants for genes for which negative selections are unavailable. Of course, the LOH-based approach can be accelerated by the application of negative selections, and we have generated homozygous HYG/HYG replacements at the LPG2 locus of L. donovani by lectin selection against lipophosphoglycan expression in this manner (23) . Similar results have been obtained at the hypoxanthineguanine phosphoribosyltransferase (HGPRT) and adenine phosphoribosyltransferase (APRT) loci of L. donovani (67) .
Null-targeting strategies as a general tool. Using the negative DHFR-TS selection and transfection of a null-targeting fragment, we were able in one step to generate Leishmania spp. deleted for both copies of DHFR-TS (Fig. 4) . This nulltargeting approach could be applied at any locus for which an appropriate negative selection can be devised, without sacrificing any selectable marker. A large number of loci are potentially suitable targets for this purpose in different species, including TK, the orotidine 5Ј-phosphate-decarboxylase locus, HGPRT, APRT, TS, or DHFR-TS. This protocol could also be used to introduce any given coding region directly into the genome, by construction of a null targeting fragment in which the negative selectable gene (DHFR-TS here) was replaced with another coding region. This would be advantageous in many circumstances, and these approaches should be feasible with cells from any diploid species.
Marker-free dhfr-ts
؊ Leishmania knockouts as attenuated live vaccine lines. In many situations, the introduction of selectable markers may not be desirable, as in organisms destined for use outside the laboratory. For example, we have shown previously that dhfr-ts Ϫ parasites have potential as live, attenuated vaccines against cutaneous leishmaniasis in a susceptible mouse model (65) . Unfortunately, the NEO resistance marker present in this line can inactivate the aminoglycoside paromomycin, which shows some efficacy in antileishmanial chemotherapy (32) . It is remotely possible that NEO genes from auxotrophic vaccine lines will find their way into natural field populations, thereby compromising paromomycin therapy. The use of marker-free knockouts described here circumvents this problem, because they lack any DHFR-TS or selectable marker coding sequences. Preliminary studies of this parasite show that its efficacy as a live vaccine is uncompromised and comparable to that of the previously studied NEO/ HYG dhfr-ts Ϫ null mutant (34) . The methods developed in this work thus permit the construction of marker-free parasites that may have clinical applications.
